News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The National Institutes of Health (NIH) Aims to Develop Drugs That Big Pharma Discarded


6/20/2013 8:23:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer’s disease, Duchenne muscular dystrophy, and schizophrenia that drug companies had abandoned because they were viewed as too risky or not lucrative enough. More than 95% of medicines that begin human testing do not reach the market. The reason might be because they are ineffective, because they are unsafe, or because a drug company stopped developing them for business reasons. But researchers have long wondered if some of these potential medicines, abandoned in one disease, might prove useful in another. There is precedent for the idea.

Help employers find you! Check out all the jobs and post your resume.

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES